Magnus Rasmussen
61 – 70 of 156
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Infective endocarditis caused by HACEK group bacteria—a registry-based comparative study
(
- Contribution to journal › Article
-
Mark
Infective Endocarditis Due to Corynebacterium Species : Clinical Features and Antibiotic Resistance
(
- Contribution to journal › Article
-
Mark
Lack of Opsonic Antibody Responses to Invasive Infections With Streptococcus dysgalactiae
(
- Contribution to journal › Article
-
Mark
Convalescence plasma treatment of COVID-19 : results from a prematurely terminated randomized controlled open-label study in Southern Sweden
(
- Contribution to journal › Article
-
Mark
Post-outbreak serological screening for SARS-CoV-2 infection in healthcare workers at a Swedish University Hospital
(
- Contribution to journal › Article
- 2020
-
Mark
Prominent Binding of Human and Equine Fibrinogen to Streptococcus equi subsp. zooepidemicus Is Mediated by Specific SzM Types and Is a Distinct Phenotype of Zoonotic Isolates
(
- Contribution to journal › Article
-
Mark
From contamination to infective endocarditis—a population-based retrospective study of Corynebacterium isolated from blood cultures
(
- Contribution to journal › Article
-
Mark
Epidemiology, bacteriology, and clinical characteristics of HACEK bacteremia and endocarditis : a population-based retrospective study
2020) In European Journal of Clinical Microbiology and Infectious Diseases(
- Contribution to journal › Article
-
Mark
Stora skillnader i överdödlighet våren 2020 utifrån födelseland
(
- Contribution to journal › Article
-
Mark
Accelerated treatment of endocarditis—The POET II trial : Rationale and design of a randomized controlled trial: Design and rationale of the POET II trial
(
- Contribution to journal › Article